Logan Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.68M | Sell |
11,087
-487
| -4% | -$73.9K | 0.08% | 172 |
|
|
2025
Q1 | $1.74M | Sell |
11,574
-10,482
| -48% | -$1.58M | 0.08% | 179 |
|
|
2024
Q4 | $4.07M | Sell |
22,056
-1,674
| -7% | -$309K | 0.17% | 127 |
|
|
2024
Q3 | $4.67M | Sell |
23,730
-275
| -1% | -$54.2K | 0.19% | 120 |
|
|
2024
Q2 | $4.96M | Sell |
24,005
-353
| -1% | -$72.9K | 0.21% | 116 |
|
|
2024
Q1 | $6.6M | Buy |
24,358
+3,201
| +15% | +$867K | 0.28% | 100 |
|
|
2023
Q4 | $5M | Sell |
21,157
-2,400
| -10% | -$567K | 0.23% | 112 |
|
|
2023
Q3 | $4.62M | Buy |
23,557
+2,832
| +14% | +$555K | 0.23% | 112 |
|
|
2023
Q2 | $4.36M | Sell |
20,725
-2,488
| -11% | -$523K | 0.21% | 120 |
|
|
2023
Q1 | $4.68M | Buy |
23,213
+889
| +4% | +$179K | 0.23% | 115 |
|
|
2022
Q4 | $4.86M | Sell |
22,324
-132
| -0.6% | -$28.8K | 0.25% | 104 |
|
|
2022
Q3 | $4.42M | Buy |
22,456
+1,866
| +9% | +$367K | 0.26% | 97 |
|
|
2022
Q2 | $4.41M | Sell |
20,590
-1,146
| -5% | -$245K | 0.25% | 104 |
|
|
2022
Q1 | $6.17M | Buy |
21,736
+416
| +2% | +$118K | 0.3% | 96 |
|
|
2021
Q4 | $8.03M | Buy |
21,320
+512
| +2% | +$193K | 0.35% | 86 |
|
|
2021
Q3 | $8.59M | Sell |
20,808
-611
| -3% | -$252K | 0.4% | 77 |
|
|
2021
Q2 | $7.92M | Buy |
21,419
+1,689
| +9% | +$625K | 0.37% | 81 |
|
|
2021
Q1 | $5.72M | Buy |
19,730
+1,468
| +8% | +$426K | 0.29% | 95 |
|
|
2020
Q4 | $4.56M | Buy |
+18,262
| New | +$4.56M | 0.23% | 109 |
|